Holds a degree in Pharmaceutical Chemistry and Technology and started his career with Dompé S.p.A, being part of the team who founded and expanded its research centre. Founding executive of Novartis Vaccine Institute for Global Health (NVGH) as Head of Technical Development and then, with GSK taking over Novartis vaccine business, as Head of Technical and Business Strategy of GVGH. Holds several patents and pioneered innovative technical developments in several fields including GMMA and glycoconjugate based vaccines. Quality Auditor and investigational products cGMP manufacturing expert. Registered Qualified Person (QP).